| 7508- | HCAs, | Natural Sources, Pharmacokinetics, Biological Activities and Health Benefits of Hydroxycinnamic Acids and Their Metabolites |
| - | Review, | Nor, | NA |
| 7506- | HCAs, | A Systematic Review and Comprehensive Evaluation of Human Intervention Studies to Unravel the Bioavailability of Hydroxycinnamic Acids |
| - | Review, | Nor, | NA |
| 7509- | HCAs, | Oral Pharmacokinetics of Hydroxycinnamic Acids: An Updated Review |
| - | Review, | Nor, | NA |
| 2400- | HCAs, | The Mixture of Ferulic Acid and P-Coumaric Acid Suppresses Colorectal Cancer through lncRNA 495810/PKM2 Mediated Aerobic Glycolysis |
| - | in-vitro, | CRC, | NA | - | in-vivo, | CRC, | NA |
| 2407- | HCAs, | 2'-hydroxycinnamaldehyde inhibits cancer cell proliferation and tumor growth by targeting the pyruvate kinase M2 |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | LNCaP |
| 6869- | HCAs, | FA, | CA, | RosA, | Exploring the potential of cinnamic acid analogues in alzheimer's disease |
| - | Review, | AD, | NA |
| 7505- | HCQ, | GEM, | PacT, | A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients |
| - | Trial, | PC, | NA |
| 1912- | HCQ, | TMZ, | Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy |
| - | in-vivo, | GBM, | U87MG |
| 1441- | HCQ, | Chemo, | Case report: stage 4 pancreatic cancer to remission using paricalcitol and hydroxychloroquine in addition to traditional chemotherapy |
| - | Case Report, | GBM, | NA |
| 1439- | HCQ, | Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine |
| - | in-vitro, | Melanoma, | NA | - | in-vitro, | CRC, | HCT116 |
| 1438- | HCQ, | Chemo, | Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme |
| - | Trial, | GBM, | NA |
| 7169- | HDN-1, | CHA, | Identification of epipolythiodioxopiperazines HDN-1 and chaetocin as novel inhibitor of heat shock protein 90 |
| - | in-vitro, | Lung, | H1975 | - | in-vitro, | Lung, | HCC827 | - | in-vitro, | Lung, | A549 |
| - | Analysis, | NA, | NA |
| 7359- | HibSad, | Novel Insight into the Cellular and Molecular Signalling Pathways on Cancer Preventing Effects of Hibiscus sabdariffa: A Review - PubMed |
| - | Review, | Var, | NA |
| 7370- | HibSad, | Hibiscus sabdariffa leaf induces apoptosis of human prostate cancer cells in vitro and in vivo |
| - | vitro+vivo, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | DU145 |
| 7369- | HibSad, | Components in aqueous Hibiscus rosa-sinensis flower extract inhibit in vitro melanoma cell growth |
| - | in-vitro, | Melanoma, | B16-BL6 | - | in-vitro, | Nor, | LA25 |
| 7367- | HibSad, | CUR, | Moringa, | CAP, | RosA | Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases |
| - | Review, | Nor, | NA |
| 7366- | HibSad, | Does consumption of an aqueous extract of Hibscus sabdariffa affect renal function in subjects with mild to moderate hypertension? |
| - | Human, | Nor, | NA |
| 7365- | HibSad, | Insight into the molecular evidence supporting the remarkable chemotherapeutic potential of Hibiscus sabdariffa L |
| - | Review, | Var, | NA |
| 7364- | HibSad, | Hibiscus sabdariffa calyx extract induces anti-proliferative and anti-migratory effects in ovarian cancer |
| - | in-vitro, | Ovarian, | OVCAR-3 |
| 7363- | HibSad, | Chemopreventive properties of Hibiscus sabdariffa L. on human gastric carcinoma cells through apoptosis induction and JNK/p38 MAPK signaling activation |
| 7362- | HibSad, | The effect of a water extract and anthocyanins of hibiscus sabdariffa L on paracetamol-induced hepatoxicity in rats |
| - | in-vivo, | Nor, | NA |
| 7361- | HibSad, | Hibiscus sabdariffa L. - a phytochemical and pharmacological review |
| - | Review, | Var, | NA |
| 7360- | HibSad, | Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa |
| - | Study, | Nor, | NA |
| 7358- | HibSad, | Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus sabdariffa Linne |
| - | Review, | Var, | NA |
| 7357- | HibSad, | Hibiscus Anthocyanins Extracts Induce Apoptosis by Activating AMP-Activated Protein Kinase in Human Colorectal Cancer Cells |
| - | in-vitro, | CRC, | LoVo |
| 7356- | HibSad, | Hibiscus flower extract selectively induces apoptosis in breast cancer cells and positively interacts with common chemotherapeutics |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 7355- | HibSad, | Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 7354- | HibSad, | Hibiscus sabdariffa Leaf Extract Inhibits Human Prostate Cancer Cell Invasion via Down-Regulation of Akt/NF-kB/MMP-9 Pathway |
| - | vitro+vivo, | Pca, | LNCaP |
| 7353- | HibSad, | Hibiscus sabdariffa Leaf Polyphenolic Extract Induces Human Melanoma Cell Death, Apoptosis, and Autophagy |
| - | in-vitro, | Melanoma, | A375 |
| 7352- | HibSad, | Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: An overview of reviews and updated dose-response meta-analysis |
| - | Review, | Nor, | NA |
| 7351- | HibSad, | Induction of apoptosis by hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression |
| - | in-vitro, | AML, | HL-60 |
| 7350- | HibSad, | Hibiscus polyphenol-rich extract induces apoptosis in human gastric carcinoma cells via p53 phosphorylation and p38 MAPK/FasL cascade pathway |
| - | in-vitro, | GC, | AGS |
| 7349- | HibSad, | Pharmacokinetics of anthocyanidin-3-glycosides following consumption of Hibiscus sabdariffa L. extract |
| - | Trial, | Nor, | NA |
| 7348- | Hne, | Apoptosis‐inducing activity of Helleborus nigerin ALL and AML |
| - | in-vitro, | AML, | NA |
| 7347- | Hne, | Study of potent cytotoxic activity of Helleborus cyclophyllus Boiss against a human adenocarcinoma cell line |
| - | NA, | Lung, | A549 |
| 7346- | Hne, | Subcutaneous application of Helleborus niger 12x in older patients with dementia-a retrospective cohort study |
| - | Trial, | AD, | NA |
| 7345- | Hne, | A root extract of Helleborus niger possess cytotoxic properties in neuroblastoma cells |
| - | in-vitro, | neuroblastoma, | NXS2 |
| 7344- | Hne, | Cardiac Glycoside Compound Isolated from Helleborus thibetanus Franch Displays Potent Toxicity against HeLa Cervical Carcinoma Cells through ROS-Independent Autophagy |
| - | in-vitro, | Cerv, | HeLa |
| 7343- | Hne, | Comparative Evaluation of the Potential Antitumor of Helleborus purpurascens in Skin and Breast Cancer |
| - | in-vitro, | Melanoma, | A431 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | HaCaT | - | in-vitro, | Nor, | JB6 |
| 7341- | Hne, | Preclinical evaluation of safety and potential of black hellebore extracts for cancer treatment |
| - | Review, | Var, | NA |
| 7340- | Hne, | Differential cytotoxic properties of Helleborus niger L. on tumour and immunocompetent cells |
| - | in-vitro, | AML, | NA |
| 7339- | Hne, | Apoptosis-inducing activity of Helleborus niger in ALL and AML |
| - | in-vitro, | AML, | NA |
| 7461- | HNK, | Honokiol: a potent chemotherapy candidate for human colorectal carcinoma |
| - | vitro+vivo, | CRC, | RKO |
| - | Study, | AD, | NA |
| 7454- | HNK, | Updated progression of honokiol in lung cancer treatment |
| - | Review, | Lung, | NA |
| 7455- | HNK, | Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies |
| - | Review, | Var, | NA |
| 7456- | HNK, | Honokiol in the treatment of triple-negative breast cancer: a network pharmacology approach and experimental validation |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 |
| 7457- | HNK, | Honokiol enhances the sensitivity of cetuximab in KRASG13D mutant colorectal cancer through destroying SNX3-retromer complex |
| - | in-vitro, | CRC, | NA |
| 7458- | HNK, | Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2 |
| - | in-vitro, | Ovarian, | OVCAR-3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid